← Companies
AXT INC
Data as of Oct 10, 2026
AXTI
CIK 1051627Lobbying
$4,650,000 in reported federal lobbying spend across 70 quarterly filings, most recently Aug 27, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Medicare/Medicaid +4$1.4M4 filings
- Medicare/Medicaid +3$560K1 filing
- Health Issues +1$360K6 filings
- Medicare/Medicaid +5$350K1 filing
- Health Issues$350K15 filings
- Budget/Appropriations +4$340K1 filing
Latest filings, Jul 2026 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Aug 27, 2026 | MCDERMOTT+ for BAXTER INTERNATIONAL Medicare/Medicaid · Health Issues Reimbursement, coding and coverage for inpatient and outpatient products.
Reimbursement, coding and coverage for inpatient and outpatient products. | $10,000 |
| Jul 27, 2026 | SUSTAINABLE STRATEGIES DC for BRAXTON COUNTY DEVELOPMENT AUTHORITY WV Urban Development/Municipalities Funding for community priorities | $20,000 |
| Jul 23, 2026 | SUMMIT HEALTH CARE CONSULTING for BAXTER HEALTHCARE CORPORATION Unspecified | $0 |
| Jul 22, 2026 | BRODY GROUP L.L.C. PUBLIC AFFAIRS for BAXTER AEROSPACE Budget/Appropriations Defense Authorization and Appropriations bills, FY-27. Issues related to Global lightening comms for Air Force Squadrons. | $30,000 |
| Jul 21, 2026 | SUMMIT HEALTH CARE CONSULTING for BAXTER HEALTHCARE CORPORATION Health Issues Parenteral nutrition Breast reconstruction surgery | $0 |
| Jul 20, 2026 | BAXTER HEALTHCARE CORPORATION Medicare/Medicaid · Health Issues · Budget/Appropriations · Taxation/Internal Revenue Code · Trade (domestic/foreign) · Defense Issues related to pharmaceutical pricing. Issues related to drug shortages. Issues related to implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act.
Issues relating to drug pricing, 340B Drug pricing, device sterilization. Is | $350,000 |